Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Aphelion Capital is a healthcare venture capital firm founded in 2005 and headquartered in the United States. The firm focuses on early and mid-stage investments in medical device and digital health companies. Aphelion Capital aims to improve patient outcomes while maintaining or lowering costs to the healthcare system. Over the years, the firm has built a reputation for its commitment to enhancing healthcare delivery through innovative technologies.
As of now, Aphelion Capital manages a diverse portfolio that includes both active companies and those that have gone public. The firm has established a strong presence in the healthcare sector, with a focus on financial discipline and collaboration with entrepreneurs. Aphelion Capital's notable milestones include successful exits to major firms, showcasing its effectiveness in identifying and nurturing promising healthcare innovations.
Aphelion Capital invests primarily in medical technologies and services that offer innovative approaches to healthcare delivery. The firm targets companies dedicated to improving clinical outcomes, particularly in the healthcare, biotech, and digital health sectors. Investment stages range from pre-seed to Series C, allowing the firm to engage with startups at various points in their development.
Check sizes typically align with the needs of early and mid-stage companies, emphasizing financial discipline in business operations. Aphelion Capital collaborates closely with entrepreneurs, providing essential support and resources necessary for long-term success. This partnership approach helps ensure that portfolio companies are well-positioned to thrive in a competitive market.
Aphelion Capital has a diverse portfolio that includes several notable companies, some of which have been acquired by major firms. Key exits include:
The portfolio consists of both active companies and those that have gone public, reflecting Aphelion Capital's ability to identify and support high-potential healthcare innovations.
Ned Scheetz - Managing Partner. Ned has extensive experience in venture capital and healthcare investments, having led numerous successful deals in the medical technology sector.
Chris Baker, MD - Clinical Partner. Dr. Baker brings clinical expertise to the firm, enhancing its ability to evaluate healthcare innovations effectively.
Jake Martellaro - Principal. Jake focuses on sourcing and evaluating investment opportunities within the healthcare sector.
John Kim, MD - Managing Director. Dr. Kim has a strong background in clinical practice and healthcare investments, contributing to the firm's strategic direction.
Shifali Singh, PhD - Clinical Associate. Shifali supports the evaluation of medical technologies and services, leveraging her academic background.
Katie Belt - Executive Assistant. Katie provides administrative support to the team, ensuring smooth operations.
Bob Mellen - Venture Partner. Bob brings a wealth of experience in venture capital and healthcare.
Robert Thomas - Venture Partner. Robert has a strong track record in healthcare investments and strategic partnerships.
To pitch to Aphelion Capital, founders should use the email address venturedeals@aphelioncap.com. It is important to include a comprehensive business plan and financial projections in the pitch deck. Response times may vary, but founders can expect acknowledgment of their submissions.
In recent months, Aphelion Capital has continued to strengthen its portfolio with investments in innovative healthcare companies. The firm remains active in the venture capital space, focusing on early and mid-stage medical technologies. Notable exits from the portfolio include acquisitions by major firms, showcasing the firm's effectiveness in identifying high-potential startups.
As of October 2023, Aphelion Capital has not publicly announced any new fund raises or leadership changes, but its ongoing investments reflect a commitment to enhancing healthcare delivery through technology.
What are Aphelion Capital's investment criteria?
Aphelion Capital focuses on early and mid-stage investments in healthcare, biotech, and digital health sectors. The firm seeks companies that demonstrate innovative approaches to healthcare delivery and are committed to improving clinical outcomes.
How can I apply or pitch to Aphelion Capital?
Founders can pitch their ideas by sending an email to venturedeals@aphelioncap.com. It is advisable to include a detailed business plan and financial projections in the pitch.
What makes Aphelion Capital different from other VC firms?
Aphelion Capital emphasizes financial discipline and collaboration with entrepreneurs. The firm provides not only capital but also strategic support and resources necessary for long-term success.
What is the geographic scope of Aphelion Capital's investments?
The firm primarily invests in companies based in the United States, focusing on the healthcare sector.
What is the typical check size for investments?
While specific check sizes are not disclosed, Aphelion Capital invests across various stages, from pre-seed to Series C, aligning with the needs of early and mid-stage companies.
What is Aphelion Capital's post-investment involvement?
Aphelion Capital actively collaborates with portfolio companies, providing mentorship, operational support, and access to its extensive network within the medical technology sector.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.